IP Verse

Genmab A/s opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Genmab A/s

Patent Number:
EP3656443
Title:
Use Of Trl Agonist And Anti-Cd47 Agent To Enhance Phagocytosis Of Cancer Cells
Applicant:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Opposition Date:
Jun 29, 2022
Patent Number:
EP3177645
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Applicant:
LINDHOFER, HORST, DR.
Opposition Date:
Nov 17, 2021
Patent Number:
EP3056514
Title:
Methods For Manipulating Phagocytosis Mediated By Cd47
Applicant:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Opposition Date:
Jan 17, 2020
Patent Number:
EP3056515
Title:
Methods For Manipulating Phagocytosis Mediated By Cd47
Applicant:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Opposition Date:
Jan 17, 2020
Patent Number:
EP2970493
Title:
Methods For Achieving Therapeutically Effective Doses Of Anti-Cd47 Agents
Applicant:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Opposition Date:
Jan 3, 2020
Patent Number:
EP2647707
Title:
Cytotoxicity-Inducing Therapeutic Agent
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Jun 12, 2019

Latest patents of Genmab A/s opposed by its competitors

Patent:
EP2943507
Grant Date:
Feb 26, 2020
Title:
Inert Format
Oppositions:
2
Patent:
EP3312196
Grant Date:
Jul 17, 2019
Title:
Antibodies Against Cd38 For Treatment Of Multiple Myeloma
Oppositions:
1
Patent:
EP2535355
Grant Date:
Jan 2, 2019
Title:
Antibodies Against Cd38 For Treatment Of Multiple Myeloma
Oppositions:
1
Patent:
EP2076769
Grant Date:
Apr 25, 2018
Title:
High Througput Methods For Characterization Of Antibodies
Oppositions:
1

Competitors of Genmab A/s

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

SECERNA LLP

AMPERSAND PARTNERSCHAFT VON RECHANWALTEN MBB

Want to track Genmab A/s?

Feel free to send us a message here and we will get back to you